Ultimate Digestion Solution
Natural health product licensed in Canada
- Licence holder
- Health Labs LLC
- NPN or DIN-HM
- 80090265
- Status
- Active licence
- Licence date
- 23 January 2019
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 150,000 Unités de papaïne du FCC | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 5 milligramme | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 150,000 Unités de papaïne du FCC | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 5 milligramme | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 515 FCC HCU | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 2.95 milligramme | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Hemicellulase | 515 FCC HCU | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Hemicellulase | 2.95 milligramme | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 4.25 FCC BGU | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 1.2 milligramme | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : bêta-Glucanase | 4.25 FCC BGU | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : bêta-Glucanase | 1.2 milligramme | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 5.5 Unité de glucoamylase du FCC | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Glucan 1,4-alpha-glucosidase | 5.5 Unité de glucoamylase du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 3,500 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 3,500 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 12.2 milligramme | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Glucan 1,4-alpha-glucosidase | 12.2 milligramme | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 87.5 milligramme | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 87.5 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Digestive enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you have gastrointestinal lesions/ulcers, are taking anticoagulant agents or anti-inflammatory agents, or are having surgery, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in such a case, discontinue use.
Source
Official Health Canada record, licence 80090265
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.